Literature DB >> 2875223

Reperfusion conditions: critical importance of total ventricular decompression during regional reperfusion.

B S Allen, F Okamoto, G D Buckberg, H Bugyi, J Leaf.   

Abstract

This study tests the hypothesis that failure to minimize left ventricular oxygen demands by venting during reperfusion diminishes recovery after controlled blood cardioplegic reperfusion. Of 25 dogs undergoing 2 hours of left anterior descending coronary occlusion, nine were reperfused with normal blood without bypass and five were reperfused with normal blood during total vented bypass. Eleven other dogs were reperfused with aspartate-glutamate-enriched, diltiazem-supplemented blood cardioplegic solution for 20 minutes during cardiopulmonary bypass; the left ventricle was decompressed by venting in only five of them. Regional systolic shortening was measured by ultrasonic crystals and myocardial damage estimated from triphenyltetrazolium chloride staining. All segments developed systolic bulging during ischemia (-23% systolic shortening, p less than 0.05), with no segmental recovery after reperfusion with normal blood without bypass (-27% systolic shortening, p less than 0.05) and negligible recovery following reperfusion with normal blood during total vented bypass (6 +/- 2%, p less than 0.05). In contrast, there was immediate recovery of regional contractility (+ 53% systolic shortening, p less than 0.05) in bypassed hearts reperfused with aspartate-glutamate-enriched, diltiazem-supplemented blood cardioplegic solution when venting was used and triphenyltetrazolium chloride nonstaining fell from 43% to 12% (p less than 0.05). Conversely, there was no postischemic recovery (-8% systolic shortening, p less than 0.05) when the same blood cardioplegic reperfusate was given over a comparable time without venting; triphenyltetrazolium chloride damage increased to 25% (p less than 0.05). Minimizing O2 demands by left ventricular decompression with venting during blood cardioplegic reperfusion is essential to ensure immediate functional recovery and limit histochemical damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875223

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  The use of mechanical assist devices in the management of cardiogenic shock. Secondary to acute myocardial infarction.

Authors:  R W Smalling
Journal:  Tex Heart Inst J       Date:  1991

2.  Myocardial protection during surgical intervention for treatment of acute myocardial infarction.

Authors:  F Beyersdorf; G D Buckberg
Journal:  Tex Heart Inst J       Date:  1992

3.  Efficacy and timing of intra-aortic counterpulsation in patients with ST-elevation myocardial infarction complicated by cardiogenic shock.

Authors:  K D Sjauw; A E Engström; M M Vis; W Boom; J Baan; R J de Winter; J G P Tijssen; J J Piek; J P S Henriques
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

Review 4.  Controlling Reperfusion Injury With Controlled Reperfusion: Historical Perspectives and New Paradigms.

Authors:  Demetria M Fischesser; Bin Bo; Rachel P Benton; Haili Su; Newsha Jahanpanah; Kevin J Haworth
Journal:  J Cardiovasc Pharmacol Ther       Date:  2021-09-17       Impact factor: 2.457

5.  Left Ventricular Assist Devices for Acute Myocardial Infarct Size Reduction: Meta-analysis.

Authors:  Satoshi Miyashita; Taro Kariya; Kelly P Yamada; Olympia Bikou; Serena Tharakan; Navin K Kapur; Kiyotake Ishikawa
Journal:  J Cardiovasc Transl Res       Date:  2020-08-28       Impact factor: 3.216

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.